The human papillomavirus (HPV) vaccine was introduced in the United States for preteens more than a dozen years ago, yet adherence rates are still below those for other childhood vaccines. Researchers at the University of Tennessee Health Science Center and Emory University have received a major grant totaling $2.7 million from the National Cancer Institute/National Institutes of Health to conduct a five-year study aimed at developing methods to improve adherence to the HPV vaccine. UTHSC will receive $1.25 million of the funding, with the remainder going to Emory and other universities collaborating on the project.
- December 2: News Medical Life Sciences